Sign in
4

Changes in Ownership

Evofem Biosciences, Inc. Filed Acc 0001209191-18-004295

Options or other derivatives

  • Chief Medical Officer acquired 7,699 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Culwell Kelly Chief Medical Officer 2018-01-17 Grant or award · Stock Option (right to buy) +7,699 7,699 D
Loading xslF345X03/doc4.xml…